Evidence mapPaperPMID 40910211Full record

ReviewCurrent drug discovery technologies2026

Basil (

Divyanshi Gupta, Harshit Chaurasia, Shivam Verma, Shreya Gupta, Vaishnavi Chauhan, Ankita Wal

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current drug discovery technologies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Divyanshi GuptaDepartment of Pharmacy, PSIT-Pranveer Singh Institute of Technology (Pharmacy), Bhauti, Kanpur, Uttar Pradesh, 209305, India.
Harshit ChaurasiaDepartment of Pharmacy, PSIT-Pranveer Singh Institute of Technology (Pharmacy), Bhauti, Kanpur, Uttar Pradesh, 209305, India.
Shivam VermaDepartment of Pharmacy, PSIT-Pranveer Singh Institute of Technology (Pharmacy), Bhauti, Kanpur, Uttar Pradesh, 209305, India.
Shreya GuptaDepartment of Pharmacy, PSIT-Pranveer Singh Institute of Technology (Pharmacy), Bhauti, Kanpur, Uttar Pradesh, 209305, India.
Vaishnavi ChauhanDepartment of Pharmacy, PSIT-Pranveer Singh Institute of Technology (Pharmacy), Bhauti, Kanpur, Uttar Pradesh, 209305, India.
Ankita WalDepartment of Pharmacy, PSIT-Pranveer Singh Institute of Technology (Pharmacy), Bhauti, Kanpur, Uttar Pradesh, 209305, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBasil, an indigenous medicinal herb, is widely used in traditional medicine for its therapeutic and cosmetic benefits. Its properties include reducing oxidative stress, increasing melatonin production, protecting cells from free radical damage, and protecting the skin. Basil can be incorporated into daily skincare routines to address various skin conditions and promote overall health. This study examines the role of basil in skin health, focusing on its antioxidant, antiinflammatory, antimicrobial, hydrating, and moisturizing properties. It examines its bioactive compounds and their impact on molecular pathways, such as NF-κB, MAPK, and COX-LOX, in reducing oxidative stress and inflammation. Additionally, it highlights basil's potential as an anti-aging agent and its applications in skincare products.

methodsThe data were gathered from various research studies and meta-analyses on basil cosmetics applications, sourced from multiple databases between 1999 and 2025, including PubMed, ScienceDirect, SpringerLink, Wiley Online Library, Elsevier, Nature, ResearchGate, and Google Scholar.

resultsBasil enhances skin health through its antioxidant, anti-inflammatory, antimicrobial, hydrating, and moisturizing effects. Its bioactive compounds, including flavonoids, phenolic acids, and terpenes, help neutralize ROS and RNS, preventing oxidative damage and inflammation. By modulating key inflammatory pathways, such as NF-κB, MAPK, and COX-LOX, Basil reduces proinflammatory cytokines and inhibits inflammatory mediators. These mechanisms contribute to its anti-aging and skin-protective properties, making it beneficial for various skincare applications. DISCUSSION: Basil is an indigenous herb with significant therapeutic potential. Traditionally, it has been used to manage various skin conditions, including acne and eczema. Studies have highlighted its anti-inflammatory and antioxidant properties, primarily due to its ability to inhibit the generation of free radicals. Additionally, basil exhibits potent antimicrobial activity, attributed to the presence of essential oils that disrupt microbial cell membranes, inhibit biofilm formation, increase membrane permeability, and lead to intracellular leakage. Owing to these multifaceted properties, basil holds promise for use in dermatological applications and cosmetic formulations.

conclusionBasil, a popular herb in various cultures, has antioxidant properties and is used in traditional medicine, skincare, and beauty treatments. Its essential oils, including linalool, estragole, and eugenol, have anti-aging, antifungal, and antibacterial properties. Basil's complex phytochemical composition makes it an excellent component for skincare, hair care, and dental care products. Its bioactive compounds neutralize reactive oxygen species and reactive nitrogen species, preventing oxidative damage and inflammation. Further research and clinical validation could enhance basil's application in dermatology and cosmetic industries.

Indexed as

CosmeceuticalsOcimum basilicumPlant ExtractsSkin CareAnimalsAnti-Inflammatory AgentsAntioxidantsHumansOxidative StressAnti-Inflammatory AgentsAntioxidantsCosmeceuticalsPlant ExtractsAnti-inflammatoryanti-microbialanti-oxidantbasildermatologyOcimum basilicumpharmacological activityskin condition

Identifiers

PMID40910211

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.